If you have not lost at least 5% body weight after compliance, you qualify for a refund
In contrast, GLP-1 receptor agonists approved by the FDAincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound, which also activates GIP receptors)are modified to resist DPP-4 degradation
Mitochondria, oxidants, and aging
A series of regional meetings were conducted in July, September, October, November and December 2024 to facilitate ongoing data collection and expert exchange
Take the first step towards achieving your beauty goals by scheduling a complimentary consultation
References: GLP1 Receptor Agonists-Effects Beyond Obesity and Diabetes